期刊文献+

食管鳞癌上纵隔1与2区淋巴结转移适形调强放疗回顾性分析 被引量:4

Conformal or intensity modulated radiotherapy for esophageal squamous cell carcinoma patients with upper mediastinal group 1,2 lymph nodes metastases
原文传递
导出
摘要 目的:探讨食管鳞癌根治术后上纵隔1与2区淋巴结转移患者放射治疗的疗效及预后影响因素。方法:回顾性分析2008-09-22-2012-04-19南京大学医学院附属鼓楼医院收治的36例食管鳞癌根治术后上纵隔1与2区淋巴结转移患者的临床资料,36例患者均接受了三维适形或调强适形放疗,联合化疗27例。生存分析和多因素分析分别采用Kaplan-Meier法和Cox比例风险模型。结果:36例患者放疗结束后总有效率(CR+PR)为77.8%(28/36),其中CR 22.2%(8/36),PR 55.6%(20/36),SD 22.2%(8/36),PD 0(0/36);中位生存期为13个月,6个月、1和2年生存率分别为70.4%、52.5%和26.0%。单因素分析显示,术后分期(P=0.015)、转移淋巴结最大径(P=0.017)、放疗剂量(P=0.027)及放疗后是否达CR(P=0.026)对于食管鳞癌术后上纵隔1与2区转移淋巴结放疗疗效有显著影响。Cox多因素分析表明,术后分期(P=0.006)和放疗剂量(P=0.010)为独立的预后影响因子。结论:食管鳞癌根治术后发生上纵隔1与2区淋巴结转移者,可采用三维适形或调强适形放疗作为补救治疗方案,术后临床分期较早或高剂量放疗组放射治疗后的预后分别优于术后分期晚及低剂量放疗组。 OBJECTIVE: To evaluate the efficacy of radiotherapy on upper mediastinal group 1,2 lymph nodes metastases from esophageal squamous cell carcinoma after radical surgery, and investigate prognostic factors. METHODS: The clinical data of 36 eases of upper mediastinal group 1,2 lymph nodes metastases from esophageal squamous cell carcinoma after radical surgery were analyzed retrospectively. All the 36 patients were treated with three dimensional conformal or intensity modulated radiotherapy. Twenty-seven patients received chemoradiotherapy. Survival and multivariate analysis were performed by methods of Kaplan-Meier and Cox regression proportional hazard model respectively. RESULTS: For all the 36 patients, the whole response rate(CRq-PR) was 77. 8% (28/36) including CR 22. 2% (8/36), PR 55. 6% (20/36), SD 22.2 % (8/36) and PD 0 (0/36) respectively. The median survival time was 13 months, while 6 months, 1 and 2 year survival rates were 70.40%,52.5 % and 26.0% respectively. Univariate analysis indicated that postoperative stage, the largest diameter of lymph node metastasis,irradiation dose and locoregional response significantly affected the prognosis (P = 0.015, P = 0.017, P = 0. 027, P = 0. 026). Cox multivariate analysis showed that the independent prognostic fac- tors were postoperative stage and irradiation dose(P = 0. 006, P= 0. 010). CONCLUSIONS: Three dimensional conformal or intensity modulated radiotherapy can be an effective salvage therapy for patients with upper mediastinal group 1,2 lymph nodes metastases from esophageal squamous cell carcinoma after radical surgery. The cases with early postoperative stage or receiving high irradiation dose after radiotherapy have statistically better prognosis.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第23期1834-1837,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 南京市卫生局课题(YKK11088)
关键词 食管肿瘤 纵隔 淋巴转移 放射治疗 预后 esophageal neoplasms mediastinum lymph node metastasis radiotherapy prognosis
  • 相关文献

参考文献12

二级参考文献69

共引文献96

同被引文献52

  • 1王玉祥,祝淑钗,李任,邱嵘,李娟.食管癌术后区域性复发的放疗[J].中华放射肿瘤学杂志,2005,14(2):86-89. 被引量:23
  • 2马剑波,季斌,施建,顾红梅.食管癌术后局部复发转移的放射治疗疗效分析[J].肿瘤防治研究,2005,32(10):656-657. 被引量:5
  • 3陈钢,王洲,刘相燕,刘凡英.胸中段食管鳞癌Ivor-Lewis手术后肿瘤复发196例临床分析[J].癌症,2006,25(1):96-99. 被引量:21
  • 4Yamamoto S, Ishihara R, Motoori M, et aL Comparison between definitive chemoradiotherapy and esopbagectomy in patients with clinical stage I esophageal squamous cell carcinoma [ J ]. Am J Gastroenterol, 2011,106 ( 6 ) : 1048 -1054.
  • 5Zhang HL,Chen LQ, Liu RL, et al. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma [ J ]. Dis Esophagus, 2010,23 ( 1 ) : 53-58.
  • 6Zhang J, Peng F, Li N, et al. Salvage concurrent radio- chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer[ J]. Radiat Oncol,2012,7:93.
  • 7Lu JC, Kong C, Tao H. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma [ J]. Int J Radiat Oncol Biol Phys,2010,78(3) :710-714.
  • 8ZhangJ, Peng F, Li N, et al. Salvage concurrent radio-chemotherapy for postoperative local recurrence of squamous-cell esophageal cancer[J]. Radiat Oncol,2012, 7(3): 93.
  • 9Eisenhauer EA, Therasse P, BogaertsJ, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.ll[J]. EurJ Cancer,2009,45(2) :228-247.
  • 10Yamamoto S, Ishihara R, Motoori M, et al. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma[J]. AmJ Gastroenterol, 2011, 106(6) :1048-1054.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部